ID   SC6A9_RAT               Reviewed;         638 AA.
AC   P28572; A1A5N0; Q63322; Q63323;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   29-MAY-2024, entry version 174.
DE   RecName: Full=Sodium- and chloride-dependent glycine transporter 1;
DE            Short=GlyT-1;
DE            Short=GlyT1;
DE   AltName: Full=Solute carrier family 6 member 9;
GN   Name=Slc6a9;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=1353889; DOI=10.1073/pnas.89.15.7189;
RA   Guastella J., Brecha N., Weigmann C., Lester H.A., Davidson N.;
RT   "Cloning, expression, and localization of a rat brain high-affinity glycine
RT   transporter.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:7189-7193(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, TISSUE SPECIFICITY, TRANSPORTER ACTIVITY, AND ACTIVITY
RP   REGULATION.
RC   TISSUE=Brain;
RX   PubMed=1534013; DOI=10.1016/0896-6273(92)90207-t;
RA   Smith K.E., Borden L.A., Hartig P.R., Branchek T.A., Weinshank R.L.;
RT   "Cloning and expression of a glycine transporter reveal colocalization with
RT   NMDA receptors.";
RL   Neuron 8:927-935(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Blood;
RX   PubMed=8494645; DOI=10.1016/0896-6273(93)90201-2;
RA   Borowsky B., Mezey E., Hoffman B.J.;
RT   "Two glycine transporter variants with distinct localization in the CNS and
RT   peripheral tissues are encoded by a common gene.";
RL   Neuron 10:851-863(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-67 (ISOFORMS 1 AND 2), AND
RP   ALTERNATIVE PROMOTER USAGE.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9786914; DOI=10.1074/jbc.273.44.29077;
RA   Borowsky B., Hoffman B.J.;
RT   "Analysis of a gene encoding two glycine transporter variants reveals
RT   alternative promoter usage and a novel gene structure.";
RL   J. Biol. Chem. 273:29077-29085(1998).
RN   [6]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH EXOC1; EXCO3 AND EXOC4.
RX   PubMed=16181645; DOI=10.1016/j.neuropharm.2005.07.021;
RA   Cubelos B., Gimenez C., Zafra F.;
RT   "The glycine transporter GLYT1 interacts with Sec3, a component of the
RT   exocyst complex.";
RL   Neuropharmacology 49:935-944(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-603 AND SER-605, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Sodium- and chloride-dependent glycine transporter
CC       (PubMed:1534013, PubMed:16181645). Essential for regulating glycine
CC       concentrations at inhibitory glycinergic synapses (By similarity).
CC       {ECO:0000250|UniProtKB:P28571, ECO:0000269|PubMed:1534013,
CC       ECO:0000269|PubMed:16181645}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(out) + glycine(out) + 2 Na(+)(out) = chloride(in) +
CC         glycine(in) + 2 Na(+)(in); Xref=Rhea:RHEA:70691, ChEBI:CHEBI:17996,
CC         ChEBI:CHEBI:29101, ChEBI:CHEBI:57305;
CC         Evidence={ECO:0000269|PubMed:1534013, ECO:0000269|PubMed:16181645};
CC   -!- ACTIVITY REGULATION: Inhibited by sarcosine.
CC       {ECO:0000269|PubMed:1534013}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=123 uM for glycine {ECO:0000269|PubMed:1534013};
CC         KM=185 uM for glycine {ECO:0000269|PubMed:16181645};
CC         Vmax=28 nmol/min/mg enzyme with glycine as substrate
CC         {ECO:0000269|PubMed:1534013, ECO:0000269|PubMed:16181645};
CC   -!- SUBUNIT: Interacts with EXOC1; interaction increases the transporter
CC       capacity of SLC6A9 probably by promoting its insertion into the cell
CC       membrane (PubMed:16181645). Interacts with EXOC3 and EXOC4
CC       (PubMed:16181645). {ECO:0000269|PubMed:16181645}.
CC   -!- INTERACTION:
CC       P28572; P31016: Dlg4; NbExp=2; IntAct=EBI-848783, EBI-375655;
CC       P28572-2; P31016: Dlg4; NbExp=4; IntAct=EBI-848796, EBI-375655;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16181645};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=1; Synonyms=GlyT-1B, GlyT-1;
CC         IsoId=P28572-2; Sequence=Displayed;
CC       Name=2; Synonyms=GlyT-1A, GlyT-2;
CC         IsoId=P28572-1; Sequence=VSP_039239;
CC   -!- TISSUE SPECIFICITY: [Isoform 1]: Found only in the white matter of the
CC       CNS. {ECO:0000269|PubMed:1534013}.
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: Found in the gray matter of CNS as
CC       well as in macrophages and mast cells in peripheral tissues.
CC       {ECO:0000269|PubMed:1353889, ECO:0000269|PubMed:8494645}.
CC   -!- SIMILARITY: Belongs to the sodium:neurotransmitter symporter (SNF) (TC
CC       2.A.22) family. SLC6A9 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M95413; AAA41256.1; -; mRNA.
DR   EMBL; M88595; AAA41257.1; -; mRNA.
DR   EMBL; L13600; AAA73557.1; -; mRNA.
DR   EMBL; BC128732; AAI28733.1; -; mRNA.
DR   EMBL; U28975; AAC71066.1; -; Genomic_DNA.
DR   EMBL; U28975; AAC71067.1; -; Genomic_DNA.
DR   PIR; I58140; I58140.
DR   PIR; JH0673; JH0673.
DR   RefSeq; NP_446270.1; NM_053818.2. [P28572-1]
DR   RefSeq; XP_006238687.1; XM_006238625.3. [P28572-2]
DR   AlphaFoldDB; P28572; -.
DR   SMR; P28572; -.
DR   BioGRID; 250476; 1.
DR   IntAct; P28572; 2.
DR   STRING; 10116.ENSRNOP00000070161; -.
DR   BindingDB; P28572; -.
DR   ChEMBL; CHEMBL4556; -.
DR   GuidetoPHARMACOLOGY; 935; -.
DR   TCDB; 2.A.22.2.2; the neurotransmitter:sodium symporter (nss) family.
DR   GlyCosmos; P28572; 4 sites, No reported glycans.
DR   GlyGen; P28572; 4 sites.
DR   iPTMnet; P28572; -.
DR   PhosphoSitePlus; P28572; -.
DR   PaxDb; 10116-ENSRNOP00000040252; -.
DR   Ensembl; ENSRNOT00000085527.2; ENSRNOP00000070161.1; ENSRNOG00000019484.7. [P28572-2]
DR   GeneID; 116509; -.
DR   KEGG; rno:116509; -.
DR   AGR; RGD:621243; -.
DR   CTD; 6536; -.
DR   RGD; 621243; Slc6a9.
DR   eggNOG; KOG3660; Eukaryota.
DR   GeneTree; ENSGT00940000157263; -.
DR   HOGENOM; CLU_006855_9_5_1; -.
DR   InParanoid; P28572; -.
DR   OMA; QHNGVQI; -.
DR   OrthoDB; 3084493at2759; -.
DR   PhylomeDB; P28572; -.
DR   TreeFam; TF343812; -.
DR   Reactome; R-RNO-442660; Na+/Cl- dependent neurotransmitter transporters.
DR   SABIO-RK; P28572; -.
DR   PRO; PR:P28572; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000019484; Expressed in cerebellum and 19 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0032279; C:asymmetric synapse; IDA:SynGO.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0031045; C:dense core granule; IDA:ARUK-UCL.
DR   GO; GO:0005768; C:endosome; IDA:ARUK-UCL.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; IDA:SynGO.
DR   GO; GO:0016328; C:lateral plasma membrane; ISO:RGD.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IDA:SynGO.
DR   GO; GO:0015187; F:glycine transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0015375; F:glycine:sodium symporter activity; IDA:UniProtKB.
DR   GO; GO:1903804; P:glycine import across plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0061537; P:glycine secretion, neurotransmission; ISO:RGD.
DR   GO; GO:0015816; P:glycine transport; ISO:RGD.
DR   GO; GO:0001504; P:neurotransmitter uptake; ISO:RGD.
DR   GO; GO:0070455; P:positive regulation of heme biosynthetic process; ISO:RGD.
DR   GO; GO:0046985; P:positive regulation of hemoglobin biosynthetic process; ISO:RGD.
DR   GO; GO:0060092; P:regulation of synaptic transmission, glycinergic; ISS:UniProtKB.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; IBA:GO_Central.
DR   CDD; cd11498; SLC6sbd_GlyT1; 1.
DR   InterPro; IPR000175; Na/ntran_symport.
DR   InterPro; IPR003028; Na/ntran_symport_glycine_GLY1.
DR   InterPro; IPR037272; SNS_sf.
DR   PANTHER; PTHR11616:SF263; SODIUM- AND CHLORIDE-DEPENDENT GLYCINE TRANSPORTER 1; 1.
DR   PANTHER; PTHR11616; SODIUM/CHLORIDE DEPENDENT TRANSPORTER; 1.
DR   Pfam; PF00209; SNF; 1.
DR   PRINTS; PR01204; GLY1TRNSPORT.
DR   PRINTS; PR00176; NANEUSMPORT.
DR   SUPFAM; SSF161070; SNF-like; 1.
DR   PROSITE; PS00610; NA_NEUROTRAN_SYMP_1; 1.
DR   PROSITE; PS00754; NA_NEUROTRAN_SYMP_2; 1.
DR   PROSITE; PS50267; NA_NEUROTRAN_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   Alternative promoter usage; Amino-acid transport; Cell membrane;
KW   Glycoprotein; Membrane; Neurotransmitter transport; Phosphoprotein;
KW   Reference proteome; Symport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..638
FT                   /note="Sodium- and chloride-dependent glycine transporter
FT                   1"
FT                   /id="PRO_0000214782"
FT   TOPO_DOM        1..40
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        41..61
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        68..88
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        120..140
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        141..217
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        218..238
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        247..267
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        292..312
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        339..359
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        382..402
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        438..458
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        462..482
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        502..522
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        542..562
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        563..638
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..30
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          627..638
FT                   /note="Essential for interaction with EXOC1"
FT                   /evidence="ECO:0000269|PubMed:16181645"
FT   COMPBIAS        9..30
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         603
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         605
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         630
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48067"
FT   CARBOHYD        169
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        172
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        182
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        188
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..15
FT                   /note="MAVAHGPVATSSPEQ -> MVGKGAKGML (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1353889,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8494645"
FT                   /id="VSP_039239"
FT   CONFLICT        50
FT                   /note="V -> W (in Ref. 5; AAC71066/AAC71067)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   638 AA;  71061 MW;  AB43FCDE767F4AFA CRC64;
     MAVAHGPVAT SSPEQNGAVP SEATKKDQNL TRGNWGNQIE FVLTSVGYAV GLGNVWRFPY
     LCYRNGGGAF MFPYFIMLVF CGIPLFFMEL SFGQFASQGC LGVWRISPMF KGVGYGMMVV
     STYIGIYYNV VICIAFYYFF SSMTHVLPWA YCNNPWNTPD CAGVLDASNL TNGSRPTALS
     GNLSHLFNYT LQRTSPSEEY WRLYVLKLSD DIGDFGEVRL PLLGCLGVSW VVVFLCLIRG
     VKSSGKVVYF TATFPYVVLT ILFVRGVTLE GAFTGIMYYL TPKWDKILEA KVWGDAASQI
     FYSLGCAWGG LITMASYNKF HNNCYRDSVI ISITNCATSV YAGFVIFSIL GFMANHLGVD
     VSRVADHGPG LAFVAYPEAL TLLPISPLWS LLFFFMLILL GLGTQFCLLE TLVTAIVDEV
     GNEWILQKKT YVTLGVAVAG FLLGIPLTSQ AGIYWLLLMD NYAASFSLVV ISCIMCVSIM
     YIYGHRNYFQ DIQMMLGFPP PLFFQICWRF VSPTIIFFIL IFTVIQYRPI TYNHYQYPGW
     AVAIGFLMAL SSVICIPLYA LFQLCRTDGD TLLQRLKNAT KPSRDWGPAL LEHRTGRYAP
     TTTPSPEDGF EVQPLHPDKA QIPIVGSNGS SRLQDSRI
//
